SEC Form 4 · accession 0001209191-16-152165
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director
Period of report
Nov 23, 2016
Accepted (ET)
Nov 28, 2016 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1 | Nov 23, 2016 | S | 93,750 | $32.00 | D | 0 | D | |
| Ordinary SharesF1 | holding | — | — | — | 15,125,393 | D | ||
| Ordinary SharesF1,F3 | holding | — | — | — | 214,531 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale transaction reported on this Form 4 was effected as part of an underwritten public offering of Ordinary Shares in the form of American Depositary Shares of the Company in which the Reporting Person was a selling shareholder.
- F3These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.